Paired tumor biopsy analysis and safety data from a pilot study evaluating Tremelimumab - a monoclonal antibody against CTLA-4 - in combination with ablative therapy in patients wi...

Por Duffy, Austin, Kerkar, Sid P, Kleiner, David E, Ulahannan, Susanna, Kurtoglu, Metin, Rusher, Oxana, Fioravanti, Suzanne, Walker, Melissa, Figg, William D, Compton, Kathryn, Venkatesan, Aradhana, Abi-Jaoudeh, Nadine, Wood, Brad, Greten, Tim F
Publicado no J Immunother Cancer (2014)

A phase I study of selumetinib (AZD6244/ARRY-142866), a MEK1/2 inhibitor, in combination with cetuximab in refractory solid tumors and KRAS mutant colorectal cancer

Por Deming, Dustin A., Cavalcante, Ludmila L., Lubner, Sam J., Mulkerin, Daniel L., LoConte, Noelle K., Eickhoff, Jens C., Kolesar, Jill M., Fioravanti, Suzanne, Greten, Tim F., Compton, Kathryn, Doyle, Austin G., Wilding, George, Duffy, Austin, Liu, Glenn
Publicado no Invest New Drugs (2015)